TRANSACTION REPORT · SEC DISCLOSURES
Gross proceeds$1.2M
Offering price$1.17
Discount to prior close0%
Warrant coverage—
Placement agent / underwriter—
Transaction overview
01Calidi Biotherapeutics, Inc. completed a $1.2M registered direct at $1.17 per share.
- Financing type
- Registered Direct
- Announcement date
- Sep 17, 2026
- Agreement date
- Sep 17, 2026
- Pricing date
- Sep 17, 2026
- Closing date
- Sep 21, 2026
- Filing date
- Sep 22, 2026
- Status
- Closed
- Market cap before announcement
- $1.7M
- Prior closing price
- $1.17
- Raise as % of market cap
- 72.4%
Market data · FMP
- Historical market cap
- $1,656,720
- Market date
- Sep 16, 2026
- Closing price
- $1.17
- Latest reported shares outstanding
- —
- Latest reported float shares
- —
- Share-data date
- —
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.
Financial Modeling Prep ↗Financing terms
02Equity
- Common shares issued
- 1,025,640
- Price per share
- $1.17
- Pre-funded warrants
- —
- Pre-financing shares disclosed in filing
- —
- Shares outstanding after financing
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- 0%
- Agent fee amount
- $0.00
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04IssuerCalidi Biotherapeutics, Inc.Issuer
Investor names: —
Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
424B5 · Calidi Biotherapeutics, Inc.SEC filing · Sep 17, 2026
Open source ↗EX-10.1 · Calidi Biotherapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-5.1 · Calidi Biotherapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗EX-99.1 · Calidi Biotherapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗8-K · Calidi Biotherapeutics, Inc.SEC filing · Sep 22, 2026
Open source ↗FMP historical market data · CLDIMarket data · Sep 16, 2026
Open source ↗Filing evidence & original calculations
gross Proceeds
1200000
gross proceeds to the Company from the Offering were approximately $1.2 millionOriginal source ↗
agent Fee Percent
0
no underwriting discounts or commissions, placement agent fees or similar compensation were paidOriginal source ↗
market Cap
FMP reported market cap; as of 2026-09-16.
{"provider": "FMP", "symbol": "CLDI", "date": "2026-09-16", "marketCap": 1656720}Original source ↗